These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 7408408)
21. Absorption and metabolism of phenytoin from tablets and capsules. Smith TC; Kinkel A Clin Pharmacol Ther; 1976 Dec; 20(6):738-42. PubMed ID: 791565 [TBL] [Abstract][Full Text] [Related]
23. Interindividual variation in the extent and rate of phenytoin accumulation. Levine M; Orr J; Chang T Ther Drug Monit; 1987 Jun; 9(2):171-6. PubMed ID: 3617156 [TBL] [Abstract][Full Text] [Related]
24. Status epilepticus in pregnancy: effect of phenytoin malabsorption on seizure control. Ramsay RE; Strauss RG; Wilder BJ; Willmore LJ Neurology; 1978 Jan; 28(1):85-9. PubMed ID: 563542 [TBL] [Abstract][Full Text] [Related]
25. Phenytoin kinetics in children. Dodson WE Clin Pharmacol Ther; 1980 May; 27(5):704-7. PubMed ID: 7371368 [TBL] [Abstract][Full Text] [Related]
26. Effect of short- and long-term alcohol use on phenytoin kinetics in chronic alcoholics. Sandor P; Sellers EM; Dumbrell M; Khouw V Clin Pharmacol Ther; 1981 Sep; 30(3):390-7. PubMed ID: 7273603 [TBL] [Abstract][Full Text] [Related]
28. Phenytoin prodrugs V: In vivo evaluation of some water-soluble phenytoin prodrugs in dogs. Varia SA; Stella VJ J Pharm Sci; 1984 Aug; 73(8):1080-7. PubMed ID: 6548519 [TBL] [Abstract][Full Text] [Related]
29. Aqueous solubility and dissolution rate does not adequately predict in vivo performance: a probe utilizing some N-acyloxymethyl phenytoin prodrugs. Stella VJ; Martodihardjo S; Rao VM J Pharm Sci; 1999 Aug; 88(8):775-9. PubMed ID: 10430541 [TBL] [Abstract][Full Text] [Related]
30. In vivo absorption of phenytoin from rat small intestine and its inhibition by phlorizin. Johansson O; Lindberg T; Melander A Acta Pharmacol Toxicol (Copenh); 1979 Oct; 45(4):265-71. PubMed ID: 525357 [TBL] [Abstract][Full Text] [Related]
31. Influence of food on the absorption of phenytoin in man. Melander A; Brante G; Johansson O; Lindberg T; Wåhlin-Boll E Eur J Clin Pharmacol; 1979 May; 15(4):269-74. PubMed ID: 477711 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic interaction between intravenous phenytoin and amiodarone in healthy volunteers. Nolan PE; Marcus FI; Hoyer GL; Bliss M; Gear K Clin Pharmacol Ther; 1989 Jul; 46(1):43-50. PubMed ID: 2743707 [TBL] [Abstract][Full Text] [Related]
37. Effect of sucralfate on phenytoin bioavailability. Hall TG; Cuddy PG; Glass CJ; Melethil S Drug Intell Clin Pharm; 1986; 20(7-8):607-11. PubMed ID: 3755676 [TBL] [Abstract][Full Text] [Related]
38. Bioavailability of phenytoin on single and multiple oral doses of two dosage forms in normal subjects. Kohda Y; Nishihara K; Isozaki S; Saitoh Y; Nakagawa F; Tamura Z J Pharmacobiodyn; 1983 Jan; 6(1):46-55. PubMed ID: 6854522 [TBL] [Abstract][Full Text] [Related]
39. Phenytoin tolerance tests. Handley AJ Br Med J; 1970 Jul; 3(5716):203-4. PubMed ID: 5448782 [TBL] [Abstract][Full Text] [Related]
40. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children. Koren G; Brand N; MacLeod SM Ther Drug Monit; 1984; 6(1):11-4. PubMed ID: 6710554 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]